Skip to main content
VALIRX PLC logo

VALIRX PLC — Investor Relations & Filings

Ticker · VAL ISIN · GB00BLH13C52 LEI · 213800VQKB9SJCQDET40 IL Professional, scientific and technical activities
Filings indexed 574 across all filing types
Latest filing 2022-01-05 Regulatory Filings
Country GB United Kingdom
Listing IL VAL

About VALIRX PLC

https://www.valirx.com/

ValiRx PLC is a life science company that accelerates the development of therapeutics and diagnostics, with a primary focus on oncology and women's health. The company's business model centers on identifying and progressing promising early-stage scientific discoveries through pre-clinical and clinical development. ValiRx provides scientific, financial, and commercial expertise to translate novel research into clinically validated treatments, aiming to improve patient outcomes in its target therapeutic areas.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1910 characters) and contains the header 'RNS Number : 4961X'. It announces a 'Price Monitoring Extension' related to trading on the London Stock Exchange. The text explicitly mentions that the information is provided by RNS, the news service of the London Stock Exchange, and is approved by the Financial Conduct Authority (FCA) as a Primary Information Provider. This structure—a brief, time-sensitive announcement disseminated via the RNS system—fits the definition of a general regulatory announcement that doesn't fit a specific financial report category. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2022-01-05 English
Signs Service Agreement with TheoremRx
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated 05 January 2022. It announces a specific corporate action: ValiRx PLC signing a Service Agreement with TheoremRx Inc. regarding the clinical trial of VAL201. The text explicitly mentions that the information is deemed to constitute 'inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014' and is provided by 'RNS, the news service of the London Stock Exchange.' This structure—an immediate announcement of material, non-public information distributed via the RNS system—is characteristic of a general regulatory filing or news service release that doesn't fit a more specific category like 10-K, ER, or DIV. Since it is a specific corporate update (a service agreement signing) distributed through the official regulatory news service, the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for such announcements.
2022-01-05 English
Amends License for VAL201 with CRT
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number' and contains information about a corporate action (amendment of a license agreement) dated December 20, 2021. It explicitly mentions that the information is deemed inside information under UK MAR and is provided by RNS, the news service of the London Stock Exchange, which acts as a Primary Information Provider. This structure strongly indicates a general regulatory announcement disseminated via the London Stock Exchange's news service, which aligns best with the 'Regulatory Filings' category (RNS), as it is not a specific financial report (10-K, IR, ER) or a specific corporate action like a dividend (DIV) or share transaction (POS).
2021-12-20 English
Evaluation agreement with Hokkaido University
M&A Activity Classification · 1% confidence The document begins with an 'RNS Number' and is dated 16 December 2021. It announces a specific corporate event: an 'Evaluation agreement with Hokkaido University' regarding a drug candidate. The text concludes with standard disclaimers and information about RNS, the news service of the London Stock Exchange, which acts as a Primary Information Provider. This structure—a brief announcement of a material event, identified by an RNS number, and distributed via the LSE's news service—is characteristic of a general regulatory announcement that doesn't fit into more specific categories like 10-K, ER, or DIV. Since it is a specific corporate update distributed via the regulatory feed, the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for such announcements.
2021-12-16 English
Live Shareholder Q&A and Investor presentations
Report Publication Announcement Classification · 1% confidence The document is an announcement from ValiRx PLC, identified by the RNS Number and dated November 11, 2021. The content explicitly invites shareholders to 'Live Shareholder Q&A and Investor presentations' scheduled for November 25 and December 7. It details the format (Zoom webinar, LSE presentation) and mentions a corporate update regarding clinical trial data. Since the document is primarily announcing upcoming investor engagement events (presentations and Q&A sessions) rather than being the transcript of a call (CT) or a formal presentation document (IP), it fits best under the category of general regulatory/investor communication. Given the nature of announcing investor events and updates, and the presence of the RNS header, it is classified as a general Regulatory Filing (RNS), as it doesn't fit the specific definitions for ER, IR, or IP, but rather serves as a broad investor relations update distributed via the RNS system.
2021-11-11 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is clearly identified by the header 'RNS Number : 6943R' and contains the standard boilerplate text indicating it is provided by RNS, the news service of the London Stock Exchange. The content itself is a 'TR-1: Standard form for notification of major holdings' detailing an acquisition or disposal of voting rights by an individual shareholder (Nicholas Slater). This type of mandatory disclosure regarding changes in significant share ownership thresholds directly corresponds to the Major Shareholding Notification category.
2021-11-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.